Accordingly, the SphK1 inhibitor SKI-I, which increases the intracellular ceramide levels and decreases S1P levels in melanoma cells, resulted in a cell cycle arrest between G2/M and S phases as well as increased apoptotic cell death, caspase-3 activation and nuclear accumulation of cleaved PARP [20]. This evidence concerns the gene SPHK1 and melanoma.